NYSEARCA:KURE KraneShares MSCI All China Health Care Index ETF (KURE) Price, Holdings, & News $19.40 -0.20 (-1.02%) Closing price 08/1/2025 04:10 PM EasternExtended Trading$19.38 -0.02 (-0.13%) As of 08/1/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock About KraneShares MSCI All China Health Care Index ETF (NYSEARCA:KURE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get KURE alerts:Sign Up Key Stats Today's Range$19.21▼$19.4650-Day Range$15.98▼$20.0952-Week Range$13.11▼$20.51Volume122,548 shsAverage Volume71,542 shsMarket Capitalization$106.70 millionAssets Under Management$111.82 millionDividend Yield0.93%Net Expense Ratio0.65%Aggregate RatingModerate Buy ETF Overview The KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector. KURE was launched on Feb 1, 2018 and is managed by KraneShares. Read More KraneShares MSCI All China Health Care Index ETF ExpensesTypeKUREHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.78%0.56%0.56%0.51%0.53%Other Expenses0.01%0.47%0.56%0.59%0.56%Total Expense0.79%0.75%0.76%0.74%0.73%Fee Waiver-0.14%-0.67%-0.66%-0.71%-0.63%Net Expense0.65%0.60%0.63%0.58%0.60% Receive KURE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for KraneShares MSCI All China Health Care Index ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address KURE ETF News HeadlinesKURE: Capitalizing On China's Healthcare RevolutionJune 24, 2025 | seekingalpha.comNew Drivers For China Health Care: AI Med-Tech Innovation, Cancer Treatment, And Favorable Balance Of TradeMarch 18, 2025 | seekingalpha.comMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alternative Assets reveals 3 urgent moves to protect your portfolio, plus the #1 asset class thriving during crises (hint: it’s not stocks or bonds). | American Alternative (Ad)KraneShares Bosera MSCI China A 50 Connect Index ETF (KBA) Dividend HistoryMarch 2, 2025 | nasdaq.comChina Market Update: The Tale Of Two China’s & Their Investors Returns!November 11, 2024 | forbes.comAmundi MSCI World Health Care UCITS ETF EUR Acc (LYXHLTW)October 8, 2024 | investing.comSee More Headlines KURE ETF - Frequently Asked Questions How have KURE shares performed this year? KraneShares MSCI All China Health Care Index ETF's stock was trading at $14.19 at the start of the year. Since then, KURE stock has increased by 36.7% and is now trading at $19.40. How do I buy shares of KraneShares MSCI All China Health Care Index ETF? Shares of KURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of KraneShares MSCI All China Health Care Index ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that KraneShares MSCI All China Health Care Index ETF investors own include Alibaba Group (BABA), NVIDIA (NVDA), Meta Platforms (META), PayPal (PYPL), Visa (V), Micron Technology (MU) and Tesla (TSLA). Fund Details IssuerKraneShares Fund NameKraneShares MSCI All China Health Care Index ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:KURE Inception Date1/31/2018 Fund ManagerMark Schlarbaum WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkMSCI China All Shares Health Care 10/40 Index CategorySector FocusHealth Care Development LevelEmerging Markets RegionAsia-Pacific Number of Holdings55 Fund Statistics Assets Under Management$111.82 million Average Daily Volume$47.48 thousand Discount/Premium-0.02% Administrator, Advisor and Custodian AdministratorSEI Investments Global Funds Services AdvisorKrane Funds Advisors, LLC CustodianBrown Brothers Harriman & Co. DistributorSEI Investments Distribution Co. Transfer AgentBrown Brothers Harriman & Co. TrusteeN/A Lead Market MakerGTS Options OptionableOptionable Options Volume10 Put Options1 Call Options10 Short Interest38,900 shs Miscellaneous Outstanding Shares5,500,000Beta0.49 Creation Unit50,000 Creation Fee$1,320.00 Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report Top 10 KURE HoldingsBEONE MEDICINES LTDHolding Weight: 8.40%Jiangsu Hengrui Medicine Co., Ltd.Holding Weight: 7.70%WuXi Biologics (Cayman) Inc.Holding Weight: 6.12%Shenzhen Mindray Bio-Medical Electronics Co., Ltd.Holding Weight: 6.01%Akeso, Inc.Holding Weight: 5.29%Innovent Biologics, Inc.Holding Weight: 4.99%CSPC Pharmaceutical Group LimitedHolding Weight: 4.46%Sino Biopharmaceutical LimitedHolding Weight: 4.24%WuXi AppTec Co., Ltd.Holding Weight: 3.39%Zhangzhou Pientzehuang Pharmaceutical., LtdHolding Weight: 2.91%Full Holdings DetailsKURE Sector ExposureKURE Industry Exposure This page (NYSEARCA:KURE) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KraneShares MSCI All China Health Care Index ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share KraneShares MSCI All China Health Care Index ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.